The PE Ratio as of December 2025 (TTM) for Handa Pharmaceuticals, Inc. (6620.TWO) is 21.93

According to Handa Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 21.93. This represents a change of 10.72% compared to the average of 19.81 of the last 4 quarters.

Handa Pharmaceuticals, Inc. (6620.TWO) Historical PE Ratio (quarterly & annually)

How has 6620.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Handa Pharmaceuticals, Inc. over the last ten years is -64.42. The current 21.93 PE Ratio has changed -3504.14% with respect to the historical average. Over the past ten years (40 quarters), 6620.TWO's PE Ratio was at its highest in in the December 2023 quarter at 72.62. The PE Ratio was at its lowest in in the March 2025 quarter at 16.74.

Handa Pharmaceuticals, Inc. (6620.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Handa Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Handa Pharmaceuticals, Inc. (6620.TWO) Average PE Ratio

How has 6620.TWO PE Ratio performed in the past?

The current PE Ratio of Handa Pharmaceuticals, Inc. (6620.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Handa Pharmaceuticals, Inc. (6620.TWO) PE Ratio vs. Peers

How is 6620.TWO’s PE Ratio compared to its peers?

Handa Pharmaceuticals, Inc.’s PE Ratio is greater than Grape King Bio Ltd (15.47), greater than TTY Biopharm Company Limited (13.25), greater than Synmosa Biopharma Corporation (20.94), greater than Alar Pharmaceuticals Inc. (-648.12), greater than YungShin Global Holding Corporation (15.94), less than ScinoPharm Taiwan, Ltd. (71.28), less than Sunmax Biotechnology Co., Ltd. (29.65), less than Great Tree Pharmacy Co., Ltd. (23.16), greater than TaiMed Biologics Inc. (-79.95), greater than EirGenix Inc. (-27.20),

Build a custom stock screener for Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Handa Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Handa Pharmaceuticals, Inc. (6620.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Handa Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.